STUART, FL. July 10, 2020 - Linical will be participating in the American Cancer Society’s CEOs Against Cancer® program, Fit2BeCancerFree®, a three week virtual step-tracking fitness challenge to be held starting July 16.
"Creating a world free from cancer can start in the workplace when we inspire our employees to live healthy and active lifestyles. About half of cancer deaths could be prevented if everyone lived a healthy lifestyle, including not smoking and maintaining a healthy weight. The Fit2BeCancerFree challenge is designed to encourage corporate leaders to lead by example, inspiring more activity among their employees throughout their workday, and helping us make a measurable difference in saving lives from cancer."
Gary M. Reedy
CEO for the American Cancer Society
The American Cancer Society currently has 15 active CEOs Against Cancer chapters nationwide with about 400 members. The CEOs Against Cancer program unites CEOs from the world’s top companies to raise awareness of high-impact cancer mission areas and collaborate with other business leaders to create a culture of health in their organizations and communities.
Linical Americas CEO, Vita Lanoce, and fellow CEOs Against Cancer members who participate in the challenge will sync a fitness tracker to a live event leaderboard powered by Movespring and hosted on cancer.org. The leaderboard will track results of the top participants throughout the day of the challenge, and the participant with the most steps logged will receive bragging rights and national recognition. Following the CEO day, the challenge will then continue with a team component for three weeks, where Linical and other participating organizations will compete in friendly competition against one another.
Fit2BeCancerFree participants also receive a nutrition and physical activity toolkit that includes tips for incorporating more physical activity into the workday and will put these tips into action starting July 16. Participants can modify their daily schedule to include “walking” meetings, taking the stairs and frequent walking breaks throughout the day, while encouraging their employees to do the same.
"As CEOs we play a critical role in partnering with the American Cancer Society to make an impact on the fight against cancer in our communities and across the country. Cancer is a serious health issue which now more than ever needs our attention. I’m looking forward to participating in the Fit2BeCancerFree CEO challenge. Through a bit of friendly competition, we can motivate employees across our companies to get moving and together we can save more lives from cancer."
Vita Lanoce
CEO of Linical Americas and member of CEOs Against Cancer Florida Chapter
The American Cancer Society is a global grassroots force of 1.5 million volunteers dedicated to saving lives, celebrating lives, and leading the fight for a world without cancer. From breakthrough research, to free lodging near treatment, a 24/7/365 live helpline, free rides to treatment, and convening powerful activists to create awareness and impact, the Society is the attacking cancer from every angle. For more information go to www.cancer.org.
Linical is a public, midsized CRO headquartered in Japan with a significant presence across North America, Europe, and Asia-Pacific. Linical provides the full spectrum of drug development services from early stage to large-scale, multinational studies. The company’s areas of expertise include Phase I-IV oncology, vaccine, infectious disease, CNS and general medicine.
The American Cancer Society is a global grassroots force of 1.5 million volunteers dedicated to saving lives, celebrating lives, and leading the fight for a world without cancer. From breakthrough research, to free lodging near treatment, a 24/7/365 live helpline, free rides to treatment, and convening powerful activists to create awareness and impact, the Society is attacking cancer from every angle. For more information go to www.cancer.org.
Linical is a public, mid-sized Contract Research Organization headquartered in Japan with a significant presence across North America, Europe, and Asia-Pacific. Linical provides the full spectrum of drug development services from early stage to large-scale, multinational studies. Our areas of focus include Phase I-IV studies in oncology, infectious disease, and CNS. Rather than be all things to the market, this intentional design allows us to provide our clients the right size, right reach, and right team.
Visit Linical's donation page to make a contribution towards cancer prevention.
Media Contacts:
Alison Cundari
Director, Marketing & Corporate Communications
acundari@linicalamericas.com
information@linicalamericas.com